IRVINE, Calif., July 29 ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will release second quarter 2009 financial results after market close on August 5, 2009. In conjunction, the Company will host a conference call at 5:00 p.m. Eastern Time to discuss these results and provide a pipeline update.
To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 37779170. This conference call also will be webcast live and archived on ISTA's website until September 5, 2009.
About ISTA Pharmaceuticals
ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $5.1 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.
Web site: http://www.istavision.com
Date: Wednesday, August 5, 2009 Time: 5:00 p.m. Eastern Time Conference call access: Internet: www.istavision.com Domestic dial-in: 866-700-7441 International dial-in: 617-213-8839 Passcode: 50706656
SOURCE ISTA Pharmaceuticals, Inc.